This post is part of a series in which TheStockAdvisors.com asked financial experts to name their top stock pick if McCain or if Obama wins the election.

"If Obama gets elected I expect him to pay great attention to domestic health care issues, in which case generic pharmaceutical companies should benefit; India-based Dr. Reddy's Laboratories (NYSE: RDY) will fare very well under such a scenario," says global stock specialist Yiannis Mostrous in The Silk Road Investor.

"The two main prospects for the company are its participation in the generic Allegra business, which could generate about $20 million in profits.

"As Dr. Reddy's has increased its U.S. pipeline filings to 60 Abbreviated New Drug Applications (ANDAs) pending approval, its U.S. business should be back on track soon.

"The second prospect is a potential merger and acquisition spree among the Indian pharmaceutical companies in an effort to face competition more effectively.

"A viable merger will allow companies to reduce research and development (R&D), as well as administrative costs, since there's an overlap when it comes to filing for the approval of similar products.